CSI Market
Sign In | Register

SSRI (SSRI) Annual Income Statement

Annual · GAAP · USD millions
Access SSRI quarterly income statements →
Reviewing income statement figures over time helps illustrate how SSRI generates earnings and manages operating expenses.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
2020 		(Dec 31 2018) (Dec 31 2017)
Revenues
Sales of Products853.09
Total Revenue853.09
Costs & Expenses
Cost of Goods and Services Sold444.54
Gross Profit0.00
Selling, Administration, Marketing33.57
Depreciation & Amortization109.26
Research & Development22.40
Total operating costs including COS0.00
Operating income / -loss188.28
Net Interest (-)Expense / Income-6.55
Loss / -Gain on Investment0.38
Foreign Currency Transaction (Gain) Loss-3.73
Other loss / -income0.00
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes201.79
Income taxes expenses / -benefit22.54
Income after income taxes158.59
Net income / -loss of other equity0.00
Income / -loss from continuing operations157.16
Non-controlling interests5.63
Preferred dividends4.88
Net income / -loss157.16
Income / -loss to shareholder151.54
EBIT208.34
EBITD208.34
EBITDA208.34
Earnings Per Share
Basic EPS (excl. extra items)0.88
Extraordinary items0.12
Basic Net EPS1.00
Basic shares outstanding (Mill. of Units)151.14
Diluted Net EPS0.96
Diluted average shares (Mill. of Units)164.44
4 historic quarters locked

Sign in to unlock the full SSRI income statement history.

Sign In Create Free Account
Get the full CSIMarket dataset: Subscribe API Connect Your AI